High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands

Ertl FJ, Friedel A, Schmid EJ, Höring C, Archipowa N, Koch P, Maschauer S, Kutta RJ, Prante O, Keller M (2025)


Publication Type: Journal article

Publication year: 2025

Journal

Book Volume: 68

Pages Range: 19482-19502

Journal Issue: 18

DOI: 10.1021/acs.jmedchem.5c01701

Abstract

Labeled ligands for the neurotensin receptor 1 (NTS1R), which is expressed in the CNS, the gastrointestinal tract, and in malignant tumors, are needed to investigate NTS1R-ligand binding and NTS1R expression. Aiming for fluorescence-labeled neurotensin(8–13)-derived NTS1R ligands with high affinity and proteolytic stability, several previous approaches were combined: (1) replacement of Arg8by an amino-functionalized carbamoylated arginine, allowing conjugation to a fluorophore, (2) Nα-methylation of Arg8and replacement of Tyr by β,β-dimethyl-l-Tyr11, conferring proteolytic stability, and (3) replacement of Leu13by trimethylsilyl-Ala, boosting binding affinity. This strategy gave fluorescent NTS1R ligands with unprecedented NTS1R binding affinity (5-TAMRA-labeled ligand 19: Ki0.14 nM, sulfo-Cy5-labeled probe 21: Ki0.094 nM) and high stability in human plasma (t1/2≫ 48 h). Their suitability for competition binding studies (flow cytometry; 19, 21) and the imaging of NTS1R expression in living cells (confocal microscopy, biomolecular imaging; 19, 21) and tumor tissue (biomolecular imaging; 21) is demonstrated.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Ertl, F.J., Friedel, A., Schmid, E.J., Höring, C., Archipowa, N., Koch, P.,... Keller, M. (2025). High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands. Journal of Medicinal Chemistry, 68(18), 19482-19502. https://doi.org/10.1021/acs.jmedchem.5c01701

MLA:

Ertl, Fabian J., et al. "High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands." Journal of Medicinal Chemistry 68.18 (2025): 19482-19502.

BibTeX: Download